Cargando…
Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer
Heat shock protein 27 (Hsp27) has an established role in tumor progression and chemo-resistance of castration-resistant prostate cancer (CRPC). Hsp27 protects eukaryotic translation initiation factor 4E (eIF4E) from degradation, thereby maintaining survival during treatment. Phenazine derivative com...
Autores principales: | Ziouziou, Hajer, Paris, Clément, Benizri, Sébastien, Le, Thi Khanh, Andrieu, Claudia, Nguyen, Dang Tan, Appavoo, Ananda, Taïeb, David, Brunel, Frédéric, Oueslati, Ridha, Siri, Olivier, Camplo, Michel, Barthélémy, Philippe, Rocchi, Palma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146835/ https://www.ncbi.nlm.nih.gov/pubmed/33925528 http://dx.doi.org/10.3390/pharmaceutics13050623 |
Ejemplares similares
-
Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
por: Ziouziou, Hajer, et al.
Publicado: (2017) -
Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
por: Ziouziou, Hajer, et al.
Publicado: (2018) -
The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer
por: Karaki, Sara, et al.
Publicado: (2015) -
Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery
por: Benizri, Sebastien, et al.
Publicado: (2018) -
Synergistic activation of eIF4A by eIF4B and eIF4G
por: Nielsen, Klaus H., et al.
Publicado: (2011)